Search Results - "Vivot, A."

Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015 by Vivot, A., Jacot, J., Zeitoun, J.-D., Ravaud, P., Crequit, P., Porcher, R.

“…Prices of anti-cancer drugs are skyrocking. We aimed to assess the clinical benefit of new drugs for treating advanced solid tumors at the time of their…”
Get full text

Impact of oxygen tension according to embryo stage of development: a prospective randomized study by Herbemont, C., Labrosse, J., Bennani-Smires, B., Cedrin-Durnerin, I., Peigne, M., Sermondade, N., Sarandi, S., Vivot, A., Vicaut, E., Talib, Z., Grynberg, M., Sifer, C.

“…Human embryo culture under 2–8% O2 is recommended by ESHRE revised guidelines for good practices in IVF labs. Nevertheless, notably due to the higher costs of…”
Get full text

Comment on: Application of a new serratus anterior plane block in modified radical mastectomy under ultrasound guidance: A prospective, randomized controlled trial by Ferreira, D., Vivot, A., Berthier, F.

Get full text

Appraisal of cancer drugs: a comparison of the French health technology assessment with value frameworks of two oncology societies by Li, J, Vivot, A, Alter, L, Durand-Zaleski, I

“…Our primary objective was to compare the grading of the value of cancer drugs ('Amélioration du Service Médical Rendu' [ASMR] level) by the French health…”
Get more information

Association of Alzheimer’s related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study by Vivot, A, Glymour, M M, Tzourio, C, Amouyel, P, Chêne, G, Dufouil, C

“…Several genetic polymorphisms have been associated with Late Onset Alzheimer’s Disease (LOAD), but there has been limited evidence on whether these…”
Get full text

Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus by Genevieve, M, Vivot, A, Gonzalez, C, Raffaitin, C, Barberger-Gateau, P, Gin, H, Rigalleau, V

“…Abstract As skin autofluorescence (AF) can assess subcutaneous accumulation of fluorescent advanced glycation end-products (AGEs), this study aimed to…”
Get full text

Magnetisation transfer parameters and stroke outcome by Sibon, I, Tourdias, T, Felix, S, Asselineau, J, Bracoud, L, Vivot, A, Rouanet, F, Renou, P, Orgogozo, J.M, Dousset, V

“…Abstract Our aim was to evaluate the association between magnetisation transfer imaging (MTI) parameters measured 30 to 45 days after a cerebrovascular insult…”
Get full text

Évaluation de l’efficacité de la toxine botulique dans le traitement du syndrome des jambes sans repos (SJSR) : étude SOXIS by Ghorayeb, I, Bénard, A, Vivot, A, Burbaud, P

Get full text

Mapping of Crowdsourcing in Health: Systematic Review by Créquit, Perrine, Mansouri, Ghizlène, Benchoufi, Mehdi, Vivot, Alexandre, Ravaud, Philippe

“…Crowdsourcing involves obtaining ideas, needed services, or content by soliciting Web-based contributions from a crowd. The 4 types of crowdsourced tasks…”
Get full text

Fetal heart rate patterns of breech presentations during expulsion. A comparative study with cephalic presentations by Bourtembourg, A, Ramanah, R, Martin, A, Pugin-Vivot, A, Maillet, R, Riethmuller, D

“…Expulsion upon vaginal delivery is a period at risk for the foetus, especially in case of breech presentation. In fact, monitoring the fetal well-being is…”
Get more information

Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? by Herbemont, Charlene, Sarandi, Solmaz, Boujenah, Jeremy, Cedrin-Durnerin, Isabelle, Sermondade, Nathalie, Vivot, Alexandre, Poncelet, Christophe, Grynberg, Michael, Sifer, Christophe

“…Clinical outcomes of 291 day-5 blastocyst transfers carried out between January 2012 and March 2016 were retrospectively compared according to their quality at…”
Get full text

Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study by Herbemont, Charlène, Chekroune, Sarah, Bonan, Sarah, Cedrin-Durnerin, Isabelle, Vivot, Alexandre, Sonigo, Charlotte, Boujenah, Jeremy, Grynberg, Michael, Sifer, Christophe

“…To determine whether post-warming culture duration (1 hour vs. 18 hours) influences implantation rates (IRs) of good-quality blastocysts (GQB) in a…”
Get full text

Efficacité et tolérance du rivaroxaban chez les patients traités pour une embolie pulmonaire by Vigneron, C., Vivot, A., Jamme, M., Gibelin, A., Briend, G., Planquette, B., Meyer, G., Sanchez, O.

“…La maladie thromboembolique veineuse (MTEV) est la troisième maladie cardiovasculaire la plus fréquente. L’embolie pulmonaire (EP) en est la manifestation la…”
Get full text

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients by LARROUY, Lucile, VIVOT, Alexandre, CHARPENTIER, Charlotte, BENARD, Antoine, VISSEAUX, Benoit, DAMOND, Florence, MATHERON, Sophie, CHENE, Geneviève, BRUN-VEZINET, Françoise, DESCAMPS, Diane

“…This study investigated the impact on virological outcome of the gag cleavage sites and the protease-coding region mutations in protease inhibitor-naive and…”
Get full text

Utilisation du cortisol salivaire nocturne dans le dépistage précoce de la récidive postopératoire de la maladie de Cushing by Danet, M, Vivot, M.-A, Nunes, M.-L, Loiseau, H, Perez, P, Tabarin, A

Get full text

Le rituximab comme traitement d’induction et d’entretien de la granulomatose avec polyangéite (Wegener). Étude de cohorte monocentrique de 114 patients by Puéchal, X., Iudici, M., Calich, A.L., Vivot, A., Terrier, B., Regent, A., Cohen, P., Le Jeunne, C., Mouthon, L., Ravaud, P., Guillevin, L.

“…Deux essais randomisés contrôlés ont montré que le rituximab (RTX) n’était pas inférieur au cyclophosphamide comme traitement d’induction de la granulomatose…”
Get full text

Patients psoriasiques non répondeurs à trois anti-TNF-alpha : étude multicentrique by Viguier, M., Livideanu, C., Richard, M.-A., Beylot-Barry, M., Vivot, A., Paul, C., Bachelez, H., Aubin, F.

Get full text

Quantification des microparticules érythrocytaires et plaquettaires dans les concentrés globulaires : impact de la méthode de production et de la conservation by Garnache-Ottou, F., Biichlé, S., Petitjean, R., Aupet, S., Naegelen, C., Vivot, A., König, F., Lartod, N., MarpauX, N., Morel, P., Bardiaux, L., Saas, P.

Get full text

R128 – Oral Surincidence des carcinomes thyroïdiens en Gironde : comparaison de la taille des tumeurs entre différents registres de cancer français by Vivot, A., Colombani, F., Trouette, H., Colonna, M., Fournier, E., Leux, C., Coureau, G., Salamon, R., Savès, M., Nicolescu-Catargi, B.

Get full text

L’analyse du rythme cardiaque fœtal au cours de l’expulsion des présentations podaliques. Analyse comparative dans une maternité de niveau III by Bourtembourg, A., Ramanah, R., Martin, A., Pugin-Vivot, A., Maillet, R., Riethmuller, D.

“…L’expulsion est une période à haut risque pour le fœtus, d’autant plus qu’il se présente par le siège. En effet, la surveillance du bien-être fœtal est…”
Get full text